Sana biotechnology to present pre-clinical data at american society of gene & cell therapy annual meeting 2021

— fusogen platform demonstrates potential for cell-specific in vivo delivery of gene therapies to multiple cell types, including t cells and hepatocytes —

SANA Ratings Summary

SANA Quant Ranking